UNITED THERAPEUTICS Corp — Director's Dealing 2021

Mar 11, 2021

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: UNITED THERAPEUTICS Corp (UTHR)
CIK: 0001082554
Period of Report: 2021-03-10

Reporting Person: Thompson Tommy G (Director)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2021-03-10	Common Stock	M	12350	$54.77	Acquired	17190	Direct
2021-03-10	Common Stock	D	12350	$159.68	Disposed	4840	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2021-03-10	Share Tracking Award	$54.77	M	12350	Disposed	2021-06-29	Common Stock (12350)	Direct

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	5800	Indirect
Common Stock	8200	Indirect

Footnotes

F1: Share tracking awards are non-dilutive cash-settled stock appreciation rights, which may only be settled in cash and may not be converted into shares of common stock. These awards were granted June 29, 2011 and were set to expire June 29, 2021.

F2: Reflects the transfer of 8,200 shares of common stock into a trust beneficially owned by the reporting person for estate planning purposes on November 2, 2020.